However, it is important to emphasize that spot reductionlosing fat from one specific area while preserving it elsewhereis not physiologically possible with any intervention, including GLP-1 therapy
The compound doesn't care whether that's breakfast, lunch, or dinner
May not be suitable for some people including pregnant or lactating women, and children aged less than eight years
6(Suppl
For mothers navigating the complex intersection of GLP-1 therapy and breastfeeding, having access to comprehensive, up-to-date research, dosage calculators , and protocol guidance can make the difference between informed confidence and anxious guessing
The STEP 1 trial showed an average weight loss of 14.9% of starting body weight over 68 weeks at this dose